FDA officials address common pitfalls affecting post-approval change applications
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)ComplianceNorth AmericaPharmaceuticalsProduct LifecycleQuality Assurance and ControlRegulatory Intelligence/Policy